Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Clin Transl Oncol ; 23(2): 378-388, 2021 Feb.
Article de Anglais | MEDLINE | ID: mdl-32638214

RÉSUMÉ

PURPOSE: To investigate the clinical significance of CX3 chemokine ligand 1(CX3CL1) and CX3CR1 in patients with bone metastasis from lung cancer. The expression levels of CX3CL1 and CX3CR1 mRNA and protein in primary lung cancer and lung cancer bone metastasis were detected by qRT-PCR and Western blot. METHODS: One hundred patients with lung cancer were divided into a boneless metastasis group (50 patients with bone metastasis) and a bone metastasis group (50 patients without distant metastasis). The bone transfer component was graded by Soloway classification (0 to III). The expression levels of serum CX3CL1-CX3CR1 axis were detected by enzyme-linked immunosorbent assay (ELISA). RT-qPCR and Western Blot were used to verify the transfection efficiency. The scratching assay was used to detect the migration of CX3CL1 to 95-D cells after down-regulating the expression of CX3CR1. RESULTS: The expression levels of CX3CL1 and CX3CR1 mRNA and protein in the primary lung cancer and lung cancer bone metastasis were significantly higher than those in the adjacent tissues (P < 0.0001). The levels of serum CX3CL1 and CX3CR1 in bone metastasis group were significantly higher than those in boneless metastasis group and healthy control group (P < 0.05). In the bone metastasis group, the levels of serum CX3CL1 and CX3CR1 were significantly positively correlated with the degree of disease progression (P < 0.01). CONCLUSION: The expression level of serum CX3CL1-CX3CR1 axis is expected to be an auxiliary reference index for monitoring bone metastasis of lung cancer.


Sujet(s)
Tumeurs osseuses/métabolisme , Tumeurs osseuses/secondaire , Récepteur-1 de la chimiokine CX3C/métabolisme , Chimiokine CX3CL1/métabolisme , Tumeurs du poumon/métabolisme , Adulte , Sujet âgé , Marqueurs biologiques tumoraux/sang , Marqueurs biologiques tumoraux/métabolisme , Technique de Western , Tumeurs osseuses/sang , Tumeurs osseuses/diagnostic , Récepteur-1 de la chimiokine CX3C/sang , Carcinome épidermoïde/sang , Carcinome épidermoïde/métabolisme , Chimiokine CX3CL1/sang , Évolution de la maladie , Régulation négative , Dépistage précoce du cancer , Test ELISA , Femelle , Humains , Tumeurs du poumon/sang , Tumeurs du poumon/anatomopathologie , Mâle , Adulte d'âge moyen , ARN messager/métabolisme , Courbe ROC , Transfection
2.
Genet Mol Res ; 14(3): 7529-37, 2015 Jul 06.
Article de Anglais | MEDLINE | ID: mdl-26214431

RÉSUMÉ

Propofol is a commonly used intravenous anesthetic. We evaluated its effects on the behavior of human pancreatic cancer cells and the underlying molecular mechanisms. The effects of propofol on Panc-1 cell proliferation, apoptosis, and invasion were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, caspase-3 activity measurement, and Matrigel invasion assay. Quantitative polymerase chain reaction (qPCR) was used to assess microRNA-133a (miR-133a) expression. Anti-miR-133a was transfected into Panc-1 cells to assess the role of miR-133a in propofol-induced antitumor activity. Propofol significantly inhibited Panc-1 cell proliferation and invasion, and promoted apoptosis. Propofol also efficiently elevated miR-133a expression. Moreover, transfection of anti-miR-133a reversed the effects of propofol on the biological behavior of Panc-1 cells. Propofol can effectively inhibit proliferation and invasion, and induce apoptosis of pancreatic cancer cells, at least partly through the upregulation of miR-133a expression.


Sujet(s)
microARN/génétique , Tumeurs du pancréas/génétique , Tumeurs du pancréas/anatomopathologie , Propofol/pharmacologie , Régulation positive/effets des médicaments et des substances chimiques , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Humains , microARN/métabolisme , Invasion tumorale , Propofol/composition chimique
3.
Genet Mol Res ; 14(2): 4058-67, 2015 Apr 27.
Article de Anglais | MEDLINE | ID: mdl-25966178

RÉSUMÉ

The Rhodobacter sphaeroides system has been used to express membrane proteins. However, its low yield has substantially limited its application. In order to promote the protein expression capability of this system, the pucC gene, which plays a crucial role in assembling the R. sphaeroides light-harvesting 2 complex (LH2), was overexpressed. To build a pucC overexpression strain, a pucC overexpression vector was constructed and transformed into R. sphaeroides CQU68. The overexpression efficiency was evaluated by quantitative real-time polymerase chain reaction. A well-used reporter ß-glucuronidase (GUS) was fusion-expressed with LH2 to evaluate the heterologous protein expression level. As a result, the cell culture and protein in the pucC overexpression strain showed much higher typical spectral absorption peaks at 800 and 850 nm compared with the non-overexpression strain, suggesting a higher expression level of LH2-GUS fusion protein in the pucC overexpression strain. This result was further confirmed by Western blot, which also showed a much higher level of heterologous protein expression in the pucC overexpression strain. We further compared GUS activity in pucC overexpression and non-overexpression strains, the results of which showed that GUS activity in the pucC overexpression strain was approximately ten-fold that in the non-overexpression strain. These results demonstrate that overexpressed pucC can promote heterologous protein expression levels in R. sphaeroides.


Sujet(s)
Protéines bactériennes/génétique , Complexe protéique du photosystème II/génétique , Rhodobacter sphaeroides/génétique , Protéines bactériennes/métabolisme , Expression des gènes , Gènes rapporteurs , Glucuronidase/génétique , Glucuronidase/métabolisme , Complexe protéique du photosystème II/métabolisme , Protéines de fusion recombinantes , Rhodobacter sphaeroides/métabolisme , Transgènes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE